Caspase-3 (CASP3)
Caspase-3 is a central executioner protease in the apoptotic cascade and belongs to the cysteine-aspartic acid protease family.
Caspase-3 is a central executioner protease in the apoptotic cascade and belongs to the cysteine-aspartic acid protease family. It is synthesized as an inactive zymogen and becomes activated by upstream initiator caspases, most notably caspase-8 and caspase-9, in response to intrinsic or extrinsic death signals. Once activated, caspase-3 cleaves a broad range of cellular substrates, including poly(ADP-ribose) polymerase (PARP) and gasdermin family proteins such as GSDME, thereby driving the biochemical and morphological features of programmed cell death.
Because of this role, caspase-3 is widely used as a biomarker of apoptosis in biomedical research and is frequently measured alongside Bax, Bcl-2, cytochrome c, PARP, and related pathway components such as Phosphatidylinositol 3-kinase (PI3K)/Protein kinase B (PKB), MAPK, TP53, and TGF-β/SMAD signaling. In cancer, neurodegeneration, liver injury, reproductive biology, and inflammatory disease models, changes in caspase-3 activity or cleavage are commonly interpreted as evidence of altered cell survival, tissue injury, or treatment response.
Where the papers sit
16 papers from the last 6 months study Caspase-3 (CASP3) directly · updated from PubMed 14 Nov 2026
Study type 0 clinical trials · 16 preclinical
Themes 3 themes
-
Apoptosis-Modulating Therapeutics
Apoptosis-modulating compounds are being explored across cancer, retinal, renal, airway and neurologic injury settings. BCL2/BAX balance, AKT signaling, ROS and caspase-3 repeatedly anchor mechanism claims. Natural products, synthetic thiazolyl hydrazones and photodynamic therapy generally aim to induce tumor-cell death, whereas other agents suppress injury-associated apoptosis. Evidence remains largely preclinical, with efficacy inferred from cell viability, migration, inflammatory markers and tissue damage.
8 papers · 50%
-
Inflammatory and Apoptotic Injury
Protective interventions are being tested against inflammatory and apoptotic tissue injury across cardiac, renal and placental settings. NF-κB, Nrf2 and caspase-3 recur as markers of oxidative stress, inflammation and cell death. Ginger and propolis extracts, siRNA nanoparticles and radiotherapy comparisons provide mainly preclinical evidence. The shared focus is tissue protection, but no single intervention or disease-specific direction dominates.
4 papers · 25%
-
Pyroptosis-Enhanced Cancer Immunotherapy
Tumor therapies are increasingly designed to convert cell death into pyroptosis and strengthen antitumor immunity. GSDME activation, glutathione disruption and immune reprogramming recur in nanoplatforms for glioblastoma, breast and colorectal cancer. XIAP-coordinated PKC signaling is being targeted to restore sensitivity to PD-1 blockade and enable rechallenge. The work is moving toward combination chemo-immunotherapy and theranostic delivery, but evidence remains preclinical.
4 papers · 25%
Papers
The 16 papers from the last 6 months that study Caspase-3 (CASP3) directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Apoptosis-Modulating Therapeutics (8)
- Trilobatin attenuates allergic airway inflammation via multi-target suppression of NLRP3 inflammasome activation and caspase-3 signaling. Molecular biology reports · 25 Oct 2026 PMID 42927572
- Revealing the mechanism of heptamethoxyflavone against diabetic kidney disease: an integrated study combining network pharmacology, molecular docking and experimental validation. Biochemical and biophysical research communications · 13 Jul 2026 PMID 42442088
- Effects of interstitial photodynamic therapy on transplanted tumors of human lung adenocarcinoma A549 cells in nude mice. Lasers in medical science · 10 Jul 2026 PMID 42429993
- Resveratrol Ameliorates PTZ-Induced Seizure Activity and Diaphragm Muscle Dysfunction by Regulating Calcium Handling and Apoptotic Pathways in Rats. Molecular neurobiology · 9 Jul 2026 PMID 42426356
- A network pharmacology-based approach and molecular docking study to explore the therapeutic potential of a nutraceutical formula (Vernolac) in the treatment of cancer. PloS one · 1 Jul 2026 PMID 42384725
- Vitexin Ameliorates HG-Induced Injury in Retinal ARPE-19 Cells by Targeting CASP3. Journal of biochemical and molecular toxicology · 25 Jun 2026 PMID 42345537
- Discovery of new thiazolyl hydrazone derivatives as anti-breast cancer agents: Synthesis, biological evaluation and in silico studies. Bioorganic chemistry · 19 Jun 2026 PMID 42320114
- Ethanolic extract of Otostegia fruticosa induces ROS-dependent apoptosis and reduces migration of MDA-MB-231 cells in vitro. PloS one · 26 May 2026 PMID 42189838
Inflammatory and Apoptotic Injury (4)
- Comparative pre- and post-treatment effects of aqueous Zingiber officinale Lsfunction in wistar rats: insights into NF-κB, Nrf2, and caspase-3 pathways. Journal of molecular histology · 14 Jul 2026 PMID 42446780
- Radiobiological effects of flattening filter and flattening filter free radiotherapy x-ray on inflammatory and apoptotic pathways in cardiac and pulmonary tissues in an MCF-7 xenograft breast cancer model. Journal of radiation research · 7 Jul 2026 PMID 42411639
- Ex vivo pretreatment of donor organ with siRNA nanoparticles attenuates cold ischemia-reperfusion injury in cardiac transplantation. Clinical science (London, England : 1979) · 24 Jun 2026 PMID 42339737
- A novel histopathological insight: caspase-3 and Azan staining reveal placental malformations ameliorated by ethanolic extract of propolis in streptozotocin-induced diabetes during gestation. Journal of molecular histology · 1 Jun 2026 PMID 42223797
Pyroptosis-Enhanced Cancer Immunotherapy (4)
- A Screening-Guided Biomimetic Exosome-Liposome Hybrid Nanoplatform Enables Pyroptosis-Enhanced Immune Reprogramming in Glioblastoma. ACS nano · 17 Jul 2026 PMID 42466899
- Development and Biological Evaluation of a GLUT-Inhibiting Theranostic Agent, MF48, for Colorectal Cancer Therapy. ACS applied bio materials · 18 Jun 2026 PMID 42315971
- Co-Delivery of Chemo and Immune Drugs by Prussian Blue Nanocubes for Combinational Therapy and T1-T2W MR Imaging of MDA-MB-231. ACS applied bio materials · 16 Jun 2026 PMID 42299821
- Targeting XIAP-coordinated PKC signaling resensitizes PD-1-refractory tumors for rechallenge. Proceedings of the National Academy of Sciences of the United States of America · 3 Jun 2026 PMID 42234523
By study type
Preclinical: animal, cell and lab studies (16)
- Trilobatin attenuates allergic airway inflammation via multi-target suppression of NLRP3 inflammasome activation and caspase-3 signaling. Molecular biology reports · 25 Oct 2026 PMID 42927572
- A Screening-Guided Biomimetic Exosome-Liposome Hybrid Nanoplatform Enables Pyroptosis-Enhanced Immune Reprogramming in Glioblastoma. ACS nano · 17 Jul 2026 PMID 42466899
- Comparative pre- and post-treatment effects of aqueous Zingiber officinale Lsfunction in wistar rats: insights into NF-κB, Nrf2, and caspase-3 pathways. Journal of molecular histology · 14 Jul 2026 PMID 42446780
- Revealing the mechanism of heptamethoxyflavone against diabetic kidney disease: an integrated study combining network pharmacology, molecular docking and experimental validation. Biochemical and biophysical research communications · 13 Jul 2026 PMID 42442088
- Effects of interstitial photodynamic therapy on transplanted tumors of human lung adenocarcinoma A549 cells in nude mice. Lasers in medical science · 10 Jul 2026 PMID 42429993
- Resveratrol Ameliorates PTZ-Induced Seizure Activity and Diaphragm Muscle Dysfunction by Regulating Calcium Handling and Apoptotic Pathways in Rats. Molecular neurobiology · 9 Jul 2026 PMID 42426356
- Radiobiological effects of flattening filter and flattening filter free radiotherapy x-ray on inflammatory and apoptotic pathways in cardiac and pulmonary tissues in an MCF-7 xenograft breast cancer model. Journal of radiation research · 7 Jul 2026 PMID 42411639
- A network pharmacology-based approach and molecular docking study to explore the therapeutic potential of a nutraceutical formula (Vernolac) in the treatment of cancer. PloS one · 1 Jul 2026 PMID 42384725
- Vitexin Ameliorates HG-Induced Injury in Retinal ARPE-19 Cells by Targeting CASP3. Journal of biochemical and molecular toxicology · 25 Jun 2026 PMID 42345537
- Ex vivo pretreatment of donor organ with siRNA nanoparticles attenuates cold ischemia-reperfusion injury in cardiac transplantation. Clinical science (London, England : 1979) · 24 Jun 2026 PMID 42339737
- Discovery of new thiazolyl hydrazone derivatives as anti-breast cancer agents: Synthesis, biological evaluation and in silico studies. Bioorganic chemistry · 19 Jun 2026 PMID 42320114
- Development and Biological Evaluation of a GLUT-Inhibiting Theranostic Agent, MF48, for Colorectal Cancer Therapy. ACS applied bio materials · 18 Jun 2026 PMID 42315971
- Co-Delivery of Chemo and Immune Drugs by Prussian Blue Nanocubes for Combinational Therapy and T1-T2W MR Imaging of MDA-MB-231. ACS applied bio materials · 16 Jun 2026 PMID 42299821
- Targeting XIAP-coordinated PKC signaling resensitizes PD-1-refractory tumors for rechallenge. Proceedings of the National Academy of Sciences of the United States of America · 3 Jun 2026 PMID 42234523
- A novel histopathological insight: caspase-3 and Azan staining reveal placental malformations ameliorated by ethanolic extract of propolis in streptozotocin-induced diabetes during gestation. Journal of molecular histology · 1 Jun 2026 PMID 42223797
- Ethanolic extract of Otostegia fruticosa induces ROS-dependent apoptosis and reduces migration of MDA-MB-231 cells in vitro. PloS one · 26 May 2026 PMID 42189838
Written from 16 PubMed abstracts, each one listed by PMID above. Published: 2026-06-28. Last written: 2026-08-26 by GPT. Drafted by language models from published abstracts; not medical advice.